Key Takeaways:
Tong Ren Tang Healthcare ranks as China's biggest private-sector hospital network focused on traditional Chinese medicine, with 1.7% of the market
Making its fourth listing bid, the company needs funds to acquire more medical institutions in an ambitious expansion plan
When it comes to traditional Chinese medicine, Tong Ren Tang remains one of the country's most trusted brands, backed by 350 years of history.
Founded by an imperial court physician, the company supplied herbal medicines to the Qing dynasty. However, the group's newer healthcare services business has taken a distinctly modern approach, pursuing an aggressive expansion strategy through multiple acquisitions.
The company, Beijing Tong Ren Tang Healthcare Investment Co. Ltd., has now launched a fourth attempt at a Hong Kong listing, seeking an injection of funds to continue along its ambitious growth path. Its application, submitted at the end of January, has CICC acting as sole sponsor.
The firm was established in 2015 to serve as Tong Ren Tang's primary provider of healthcare services using traditional Chinese medicine (TCM). If it finally achieves its IPO goal, the services company will become the group's fourth listed entity. The already floated businesses, Tong Ren Tang (600085.SH), Tong Ren Tang Technologies (1666.HK) and Tong Ren Tang Chinese Medicine (3613.HK), focus on manufacturing and sales of TCM products.
Meanwhile, the group's as-yet unlisted healthcare services operator has built a business model in which it runs clinics, provides management services for medical partners and delivers digital healthcare consultations. The network includes 12 self-owned medical institutions, 12 managed institutions and one internet hospital. The company logged around 2.98 million outpatient visits across its online and offline business in 2024, making it the largest TCM-focused hospital group in China, outside of the public sector, with a market share of 1.7%.
But despite its market position, Tong Ren Tang Healthcare suffers from obvious weaknesses in its earnings profile. The company ...
